270 related articles for article (PubMed ID: 7706774)
61. The human genes for desmogleins (DSG1 and DSG3) are located in a small region on chromosome 18q12.
Wang Y; Amagai M; Minoshima S; Sakai K; Green KJ; Nishikawa T; Shimizu N
Genomics; 1994 Apr; 20(3):492-5. PubMed ID: 8034325
[TBL] [Abstract][Full Text] [Related]
62. HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus.
Miyagawa S; Amagai M; Niizeki H; Yamashina Y; Kaneshige T; Nishikawa T; Shirai T; Inoko H
Tissue Antigens; 1999 Oct; 54(4):333-40. PubMed ID: 10551416
[TBL] [Abstract][Full Text] [Related]
63. Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression.
Miyagawa S; Amagai M; Iida T; Yamamoto Y; Nishikawa T; Shirai T
Br J Dermatol; 1999 Dec; 141(6):1084-7. PubMed ID: 10606856
[TBL] [Abstract][Full Text] [Related]
64. Autoantibodies against desmocollins in European patients with pemphigus.
Müller R; Heber B; Hashimoto T; Messer G; Müllegger R; Niedermeier A; Hertl M
Clin Exp Dermatol; 2009 Dec; 34(8):898-903. PubMed ID: 19456767
[TBL] [Abstract][Full Text] [Related]
65. Targetting of desmoglein 1 in inherited and acquired skin diseases.
Whittock NV; Bower C
Clin Exp Dermatol; 2003 Jul; 28(4):410-5. PubMed ID: 12823304
[TBL] [Abstract][Full Text] [Related]
66. Pemphigus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo selvagem, and pemphigus vulgaris. Cooperative Group on Fogo Selvagem Research.
Santi CG; Maruta CW; Aoki V; Sotto MN; Rivitti EA; Diaz LA
J Am Acad Dermatol; 1996 Jan; 34(1):40-6. PubMed ID: 8543693
[TBL] [Abstract][Full Text] [Related]
67. Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients.
Eyre RW; Stanley JR
J Exp Med; 1987 Jun; 165(6):1719-24. PubMed ID: 2438368
[TBL] [Abstract][Full Text] [Related]
68. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins.
Sekiguchi M; Futei Y; Fujii Y; Iwasaki T; Nishikawa T; Amagai M
J Immunol; 2001 Nov; 167(9):5439-48. PubMed ID: 11673563
[TBL] [Abstract][Full Text] [Related]
69. [Pemphigus. Loss of desmosomal cell-cell contact].
Schmidt E; Bröcker EB; Zillikens D
Hautarzt; 2000 May; 51(5):309-18. PubMed ID: 10875067
[TBL] [Abstract][Full Text] [Related]
70. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
Femiano F
Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
[TBL] [Abstract][Full Text] [Related]
71. Making sense of antigens and antibodies in pemphigus.
Anhalt GJ
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):763-6. PubMed ID: 10321608
[No Abstract] [Full Text] [Related]
72. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris.
Harman KE; Gratian MJ; Shirlaw PJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2002 Apr; 146(4):684-7. PubMed ID: 11966706
[TBL] [Abstract][Full Text] [Related]
73. Atypical pemphigus associated with monoclonal IgA gammopathy.
Miyagawa S; Hashimoto T; Ohno H; Nakagawa A; Watanabe K; Nishikawa T; Shirai T
J Am Acad Dermatol; 1995 Feb; 32(2 Pt 2):352-7. PubMed ID: 7829739
[TBL] [Abstract][Full Text] [Related]
74. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
[TBL] [Abstract][Full Text] [Related]
75. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
[TBL] [Abstract][Full Text] [Related]
76. Pemphigus foliaceus antibodies and a monoclonal antibody to desmoglein I demonstrate stratified squamous epithelial-specific epitopes of desmosomes.
Rubinstein N; Stanley JR
Am J Dermatopathol; 1987 Dec; 9(6):510-4. PubMed ID: 2451447
[TBL] [Abstract][Full Text] [Related]
77. Development of a Desmocollin-3 Active Mouse Model Recapitulating Human Atypical Pemphigus.
Lotti R; Atene CG; Marconi A; Di Rocco G; Reggiani Bonetti L; Zanocco Marani T; Pincelli C
Front Immunol; 2019; 10():1387. PubMed ID: 31275323
[TBL] [Abstract][Full Text] [Related]
78. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus.
Amagai M; Hashimoto T; Shimizu N; Nishikawa T
J Clin Invest; 1994 Jul; 94(1):59-67. PubMed ID: 8040292
[TBL] [Abstract][Full Text] [Related]
79. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.
Oktarina DA; van der Wier G; Diercks GF; Jonkman MF; Pas HH
Br J Dermatol; 2011 Sep; 165(3):552-62. PubMed ID: 21692763
[TBL] [Abstract][Full Text] [Related]
80. Pemphigus foliaceus sera recognize an N-terminal fragment of bovine desmoglein 1.
Olague-Alcala M; Giudice GJ; Diaz LA
J Invest Dermatol; 1994 Jun; 102(6):882-5. PubMed ID: 8006451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
